Ohlin M - Search Results

1

Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.

Axelsson F, Adler SP, Lamarre A, Ohlin M. Axelsson F, et al. Among authors: ohlin m. Vaccine. 2007 Dec 21;26(1):41-6. doi: 10.1016/j.vaccine.2007.10.048. Epub 2007 Nov 9. Vaccine. 2007. PMID: 18063447

2

Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.

Ohlin M, Hinkula J, Broliden PA, Grunow R, Borrebaeck CA, Wahren B. Ohlin M, et al. Clin Exp Immunol. 1992 Aug;89(2):290-5. doi: 10.1111/j.1365-2249.1992.tb06947.x. Clin Exp Immunol. 1992. PMID: 1379134 Free PMC article.

3

Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B.

Ohlin M, Owman H, Rioux JD, Newkirk MM, Borrebaeck CA. Ohlin M, et al. Mol Immunol. 1994 Sep;31(13):983-91. doi: 10.1016/0161-5890(94)90093-0. Mol Immunol. 1994. PMID: 7521934

4

Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.

Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA. Ohlin M, et al. J Virol. 1993 Feb;67(2):703-10. doi: 10.1128/JVI.67.2.703-710.1993. J Virol. 1993. PMID: 7678304 Free PMC article.

5

Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques.

Ohlin M, Silvestri M, Sundqvist VA, Borrebaeck CA. Ohlin M, et al. Clin Diagn Lab Immunol. 1997 Jan;4(1):107-11. doi: 10.1128/cdli.4.1.107-111.1997. Clin Diagn Lab Immunol. 1997. PMID: 9008292 Free PMC article.

6

Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.

Speckner A, Glykofrydes D, Ohlin M, Mach M. Speckner A, et al. Among authors: ohlin m. J Gen Virol. 1999 Aug;80 ( Pt 8):2183-2191. doi: 10.1099/0022-1317-80-8-2183. J Gen Virol. 1999. PMID: 10466818

7

Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region.

Furebring C, Speckner A, Mach M, Sandlie I, Norderhaug L, Borrebaeck CA, Turesson H, Ohlin M. Furebring C, et al. Among authors: ohlin m. Mol Immunol. 2002 Mar;38(11):833-40. doi: 10.1016/s0161-5890(01)00119-5. Mol Immunol. 2002. PMID: 11922941

8

Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.

Lantto J, Lindroth Y, Ohlin M. Lantto J, et al. Among authors: ohlin m. Eur J Immunol. 2002 Jun;32(6):1659-69. doi: 10.1002/1521-4141(200206)32:6<1659::AID-IMMU1659>3.0.CO;2-9. Eur J Immunol. 2002. PMID: 12115649 Free article.

9

A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.

Lantto J, Fletcher JM, Ohlin M. Lantto J, et al. Among authors: ohlin m. J Gen Virol. 2002 Aug;83(Pt 8):2001-2005. doi: 10.1099/0022-1317-83-8-2001. J Gen Virol. 2002. PMID: 12124464

10

Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.

Lantto J, Fletcher JM, Ohlin M. Lantto J, et al. Among authors: ohlin m. Virology. 2003 Jan 5;305(1):201-9. doi: 10.1006/viro.2002.1752. Virology. 2003. PMID: 12504553 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters